| Title : Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs - Bradley_2020_Nat.Chem.Biol_16_240 |
| Author(s) : Bradley SJ , Molloy C , Valuskova P , Dwomoh L , Scarpa M , Rossi M , Finlayson L , Svensson KA , Chernet E , Barth VN , Gherbi K , Sykes DA , Wilson CA , Mistry R , Sexton PM , Christopoulos A , Mogg AJ , Rosethorne EM , Sakata S , John Challiss RA , Broad LM , Tobin AB |
| Ref : Nat Chemical Biology , 16 :240 , 2020 |
| Abstract : |
| PubMedSearch : Bradley_2020_Nat.Chem.Biol_16_240 |
| PubMedID: 32080630 |
| Title : Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs - Bradley_2020_Nat.Chem.Biol_16_240 |
| Author(s) : Bradley SJ , Molloy C , Valuskova P , Dwomoh L , Scarpa M , Rossi M , Finlayson L , Svensson KA , Chernet E , Barth VN , Gherbi K , Sykes DA , Wilson CA , Mistry R , Sexton PM , Christopoulos A , Mogg AJ , Rosethorne EM , Sakata S , John Challiss RA , Broad LM , Tobin AB |
| Ref : Nat Chemical Biology , 16 :240 , 2020 |
| Abstract : |
| PubMedSearch : Bradley_2020_Nat.Chem.Biol_16_240 |
| PubMedID: 32080630 |
| Title : Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs - Bradley_2020_Nat.Chem.Biol_16_240 |
| Author(s) : Bradley SJ , Molloy C , Valuskova P , Dwomoh L , Scarpa M , Rossi M , Finlayson L , Svensson KA , Chernet E , Barth VN , Gherbi K , Sykes DA , Wilson CA , Mistry R , Sexton PM , Christopoulos A , Mogg AJ , Rosethorne EM , Sakata S , John Challiss RA , Broad LM , Tobin AB |
| Ref : Nat Chemical Biology , 16 :240 , 2020 |
| Abstract : |
| PubMedSearch : Bradley_2020_Nat.Chem.Biol_16_240 |
| PubMedID: 32080630 |
| Title : Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study - Nauck_2009_Int.J.Clin.Pract_63_46 |
| Author(s) : Nauck MA , Ellis GC , Fleck PR , Wilson CA , Mekki Q |
| Ref : Int J Clin Pract , 63 :46 , 2009 |
| Abstract : |
| PubMedSearch : Nauck_2009_Int.J.Clin.Pract_63_46 |
| PubMedID: 19125992 |
| Title : Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study - Nauck_2009_Int.J.Clin.Pract_63_46 |
| Author(s) : Nauck MA , Ellis GC , Fleck PR , Wilson CA , Mekki Q |
| Ref : Int J Clin Pract , 63 :46 , 2009 |
| Abstract : |
| PubMedSearch : Nauck_2009_Int.J.Clin.Pract_63_46 |
| PubMedID: 19125992 |
| Title : Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study - Nauck_2009_Int.J.Clin.Pract_63_46 |
| Author(s) : Nauck MA , Ellis GC , Fleck PR , Wilson CA , Mekki Q |
| Ref : Int J Clin Pract , 63 :46 , 2009 |
| Abstract : |
| PubMedSearch : Nauck_2009_Int.J.Clin.Pract_63_46 |
| PubMedID: 19125992 |